FDA approves first immunotherapy regimen for breast cancer

(CNN)The US Food and Drug Administration has granted its first approval to an immunotherapy regimen for breast cancer, the agency announced Friday. Dr. Otis Brawley, Bloomberg Distinguished Professor of oncology and epidemiology at Johns Hopkins University, said the FDA’s decision to grant the treatment accelerated approval was “the right thing to do” but cautioned that it’s not the end of the story. “The FDA has approved it based on progression-free survival with the hope that later on … data will show that the treatment actually makes women live longer,” said Brawley, who was not involved in researching the treatment. This FDA says it grants accelerated approvals to “drugs that treat serious conditions, and that fill an unmet medical need” based …